377 related articles for article (PubMed ID: 17875589)
1. Economic evaluation of Haemophilus influenzae type B vaccination in Indonesia: a cost-effectiveness analysis.
Broughton EI
J Public Health (Oxf); 2007 Dec; 29(4):441-8. PubMed ID: 17875589
[TBL] [Abstract][Full Text] [Related]
2. Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia.
Gessner BD; Sedyaningsih ER; Griffiths UK; Sutanto A; Linehan M; Mercer D; Mulholland EK; Walker DG; Steinhoff M; Nadjib M
Pediatr Infect Dis J; 2008 May; 27(5):438-43. PubMed ID: 18398383
[TBL] [Abstract][Full Text] [Related]
3. The burden of Haemophilus influenzae type b disease in Australia and an economic appraisal of the vaccine PRP-OMP.
Harris A; Hendrie D; Bower C; Payne J; de Klerk N; Stanley F
Med J Aust; 1994 Apr; 160(8):483-8. PubMed ID: 8170423
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of Haemophilus influenzae type b (Hib) vaccine introduction in the universal immunization schedule in Haryana State, India.
Gupta M; Prinja S; Kumar R; Kaur M
Health Policy Plan; 2013 Jan; 28(1):51-61. PubMed ID: 22407018
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian Federation.
Platonov AE; Griffiths UK; Voeykova MV; Platonova OV; Shakhanina IL; Chistyakova GG; Robertson SE;
Vaccine; 2006 Mar; 24(13):2367-76. PubMed ID: 16413949
[TBL] [Abstract][Full Text] [Related]
6. Pneumonia Prevention during a Humanitarian Emergency: Cost-effectiveness of Haemophilus Influenzae Type B Conjugate Vaccine and Pneumococcal Conjugate Vaccine in Somalia.
Gargano LM; Hajjeh R; Cookson ST
Prehosp Disaster Med; 2015 Aug; 30(4):402-11. PubMed ID: 26061190
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of Haemophilus influenzae type b conjugate vaccine program in Florida.
Midani S; Ayoub EM; Rathore MH
J Fla Med Assoc; 1995 Jun; 82(6):401-2. PubMed ID: 7643054
[TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries.
Cook J; Jeuland M; Whittington D; Poulos C; Clemens J; Sur D; Anh DD; Agtini M; Bhutta Z;
Vaccine; 2008 Nov; 26(50):6305-16. PubMed ID: 18835415
[TBL] [Abstract][Full Text] [Related]
9. Foresight in medicine: current challenges with Haemophilus influenzae type b conjugate vaccines.
Eskola J
J Intern Med; 2010 Mar; 267(3):241-50. PubMed ID: 20201918
[TBL] [Abstract][Full Text] [Related]
10. Age- and cause-specific childhood mortality in Lombok, Indonesia, as a factor for determining the appropriateness of introducing Haemophilus influenzae type b and pneumococcal vaccines.
Nelson CM; Sutanto A; Gessner BD; Suradana IG; Steinhoff MC; Arjoso S
J Health Popul Nutr; 2000 Dec; 18(3):131-8. PubMed ID: 11262765
[TBL] [Abstract][Full Text] [Related]
11. Economic evaluation of a routine rotavirus vaccination programme in Indonesia.
Wilopo SA; Kilgore P; Kosen S; Soenarto Y; Aminah S; Cahyono A; Ulfa M; Tholib A
Vaccine; 2009 Nov; 27 Suppl 5():F67-74. PubMed ID: 19931723
[TBL] [Abstract][Full Text] [Related]
12. New vaccines against otitis media: projected benefits and cost-effectiveness.
O'Brien MA; Prosser LA; Paradise JL; Ray GT; Kulldorff M; Kurs-Lasky M; Hinrichsen VL; Mehta J; Colborn DK; Lieu TA
Pediatrics; 2009 Jun; 123(6):1452-63. PubMed ID: 19482754
[TBL] [Abstract][Full Text] [Related]
13. Impact of non-routine vaccination on the incidence of invasive Haemophilus influenzae type b (Hib) disease: experience in the autonomous region of Valencia, Spain.
Díez-Domingo J; Pereiró I; Morant A; Gimeno C; San-Martín M; González A;
J Infect; 2001 May; 42(4):257-60. PubMed ID: 11545568
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of Haemophilus influenzae type b vaccine in Vietnam.
Le P; Griffiths UK; Anh DD; Franzini L; Chan W; Swint JM
Vaccine; 2015 Aug; 33(36):4639-46. PubMed ID: 26044493
[TBL] [Abstract][Full Text] [Related]
15. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
Griffiths UK; Hutton G; Das Dores Pascoal E
Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
[TBL] [Abstract][Full Text] [Related]
16. Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries.
Atherly D; Dreibelbis R; Parashar UD; Levin C; Wecker J; Rheingans RD
J Infect Dis; 2009 Nov; 200 Suppl 1():S28-38. PubMed ID: 19817610
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai children.
Chotivitayatarakorn P; Chotivitayatarakorn P; Poovorawan Y
Southeast Asian J Trop Med Public Health; 2010 Jan; 41(1):114-25. PubMed ID: 20578490
[TBL] [Abstract][Full Text] [Related]
18. Introducing new vaccines in developing countries: concepts and approaches to estimating burden of Haemophilus influenzae type b-associated disease.
Kilgore PE; Nyambat B
J Health Popul Nutr; 2004 Sep; 22(3):246-56. PubMed ID: 15609777
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.
Shepard CW; Ortega-Sanchez IR; Scott RD; Rosenstein NE;
Pediatrics; 2005 May; 115(5):1220-32. PubMed ID: 15867028
[TBL] [Abstract][Full Text] [Related]
20. NTAGI subcommittee recommendations on Haemophilus influenzae type B (Hib) vaccine introduction in India.
Subcommittee on Introduction of Hib Vaccine in Universal Immunization Program, National Technical Advisory Group on Immunization, India
Indian Pediatr; 2009 Nov; 46(11):945-54. PubMed ID: 19955578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
